SCHEDULE 13G/A//SEC Filing
Lyell Immunopharma, Inc. SCHEDULE 13G/A
Accession 0001104659-25-013912
CIK 0001704131other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 2:20 PM ET
Size
23.1 KB
Accession
0001104659-25-013912
Documents
Issuer
Foresite Capital Fund IV, L.P.
CIK 0001704131
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001704131
Filing Metadata
- Form type
- SCHEDULE 13G/A
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 2:20 PM ET
- Size
- 23.1 KB